Evidence map›Paper›PMID 37054849›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2023

The impact of vitamin D on cancer: A mini review.

Gerbenn Seraphin, Sandra Rieger, Martin Hewison, Enrico Capobianco, Thomas S Lisse

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Potential Value of a Combination ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Article
  11. International journal of molecular sciences · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Gerbenn SeraphinUniversity of Miami, Department of Biology, Coral Gables, FL, USA.
Sandra RiegerUniversity of Miami, Department of Biology, Coral Gables, FL, USA; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
Martin HewisonUniversity of Birmingham, Institute of Metabolism and Systems Research, Birmingham, UK.
Enrico CapobiancoThe Jackson Laboratory, Farmington, CT, USA.
Thomas S LisseUniversity of Miami, Department of Biology, Coral Gables, FL, USA; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA; iCURA LLC, Malvern, PA, USA. Electronic address: tlisse@icuradx.com.
University of Miami · USJackson Laboratory · USUniversity of Birmingham · GB

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Paul Robson · 1985 to 2026
$61.9M
(PQ 9) Dysregulation of epidermal MMP-13 as cause of paclitaxel-induced peripheral neuropathyR01CA215973 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI RIEGER, SANDRA · 2017 to 2021
$1.7M
NCI NIH HHS P30 CA034196NCI NIH HHS R01 CA215973
6 · The paper itself

Abstract

In this review, we summarize the most recent advances in vitamin D cancer research to provide molecular clarity, as well as its translational trajectory across the cancer landscape. Vitamin D is well known for its role in regulating mineral homeostasis; however, vitamin D deficiency has also been linked to the development and progression of a number of cancer types. Recent epigenomic, transcriptomic, and proteomic studies have revealed novel vitamin D-mediated biological mechanisms that regulate cancer cell self-renewal, differentiation, proliferation, transformation, and death. Tumor microenvironmental studies have also revealed dynamic relationships between the immune system and vitamin D's anti-neoplastic properties. These findings help to explain the large number of population-based studies that show clinicopathological correlations between circulating vitamin D levels and risk of cancer development and death. The majority of evidence suggests that low circulating vitamin D levels are associated with an increased risk of cancers, whereas supplementation alone or in combination with other chemo/immunotherapeutic drugs may improve clinical outcomes even further. These promising results still necessitate further research and development into novel approaches that target vitamin D signaling and metabolic systems to improve cancer outcomes.

Indexed as

Antineoplastic AgentsNeoplasmsVitamin D DeficiencyHumansProteomicsReceptors, CalcitriolVitamin DVitaminsAntineoplastic AgentsReceptors, CalcitriolVitamin DVitaminsBreast cancerCancerColorectal cancerEMTEpithelial to mesenchymal transitionMetastasisMicroenvironmentOsteoblastOsteosarcomaOxidative stressProstate cancerTumorVDRVitamin DVitamin D deficiencyVitamin D receptor

Identifiers

PMID37054849
PMCPMC10330295
OpenAlexW4364375036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.